How Much Excess Body Weight, Blood Pressure, Triglyceride, or Age Can Double the Likelihood of Diabetes Type 2?

被引:0
作者
Afshar, Parya Jangipour [1 ,2 ]
Najafipour, Hamid [3 ]
Farokhi, Mitra Shadkam [4 ]
Shahesmaeili, Armita [5 ,6 ]
机构
[1] Kerman Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Kerman, Iran
[2] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran
[3] Kerman Univ Med Sci, Cardiovasc Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran
[4] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran
[5] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran
[6] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance Inst Futur, Kerman, Iran
关键词
Diabetes; Risk factor; Odds ratio; MASS INDEX; RISK; TRAJECTORIES; ADULTHOOD; OBESITY; RATIO;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: We aimed to identify the level of known risk factors of diabetes associated with doubled likelihood of diabetes type 2. Methods: In this cross-sectional study, an analysis was performed on the data of 9930 individuals aged 15 yr and older participating from 2014 to 2018 in the second phase of the Kerman coronary artery disease risk factors study (KERCADRS), Kerman, Iran. Data were collected using a standard questionnaire. Multivariable logistic regression was performed to identify factors associated with doubled chance of diabetes. Results: The mean age of participants was 46.1 +/- 15.5 yr from which 59.5% were women. Overall, 1105 (11.1%) individuals had type 2 diabetes. An increase of 13.86 yr in age, an increase of 17.32 kg/m(2) unit in the amount of body mass index, an increase of 0.17 in the waist-to-hip ratio, a 77 mmHg increase in systolic blood pressure and 6.07 unit increase in triglyceride to HDL ratio doubled the chances of developing type 2 diabetes. Conclusion: Slight changes in the waist-to-hip circumference ratio (0.17), aging (14 yr), and increase in TGITIDL ratio (6.07 unit) were the most important risk factors, while intense physical activity was the most important protective factor associated with doubling of the chances of developing diabetes. Since most of these risk factors are modifiable, increase in physical activity and providing facilities to improve lifestyle in the community seems necessary.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 50 条
  • [21] Excess Body Weight and Cancer Risk in Patients with Type 2 Diabetes Who Were Registered in Swedish National Diabetes Register - Register-Based Cohort Study in Sweden
    Jonasson, Junmei Miao
    Cederholm, Jan
    Gudbjornsdottir, Soffia
    PLOS ONE, 2014, 9 (09):
  • [22] Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes
    G.T.C. Ko
    J.C.N. Chan
    C.C. Chow
    V.T.F. Yeung
    W.B. Chan
    W.Y. So
    R.C.W. Ma
    R. Ozaki
    C.S. Cockram
    Acta Diabetologica, 2003, 40 (2) : 80 - 84
  • [23] Concurrent Control of Blood Glucose, Body Mass, and Blood Pressure in Patients With Type 2 Diabetes: An Analysis of Data From Electronic Medical Records
    McAdam-Marx, Carrie
    Bouchard, Jonathan
    Aagren, Mark
    Conner, Chris
    Brixner, Diana I.
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 110 - 120
  • [24] Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?
    Kim, Chul Sik
    Kim, Soo-Kyung
    Araneta, Maria Rosario G.
    Lee, Eun Jig
    Barrett-Connor, Elizabeth
    Huh, Kab Bum
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1085 - 1091
  • [25] Glycated Hemoglobin and Blood Pressure Levels in Adults With Type 2 Diabetes: How Many Patients Are on Target?
    de Farias, Camila Bergonsi
    Coelli, Sabrina
    Satler, Fabiola
    Brondani, Leticia
    Zelmanovitz, Themis
    Silveiro, Sandra Pinho
    CANADIAN JOURNAL OF DIABETES, 2021, 45 (04) : 334 - 340
  • [26] Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis
    Tsapas, Apostolos
    Karagiannis, Thomas
    Kakotrichi, Panagiota
    Avgerinos, Ioannis
    Mantsiou, Chrysanthi
    Tousinas, Georgios
    Manolopoulos, Apostolos
    Liakos, Aris
    Malandris, Konstantinos
    Matthews, David R.
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2021, 23 (09) : 2116 - 2124
  • [27] Effects of Okchun-San, a herbal formulation, on blood glucose levels and body weight in a model of Type 2 diabetes
    Chang, MS
    Oh, MS
    Kim, DR
    Jung, KJ
    Park, S
    Choi, SB
    Ko, BS
    Park, SK
    JOURNAL OF ETHNOPHARMACOLOGY, 2006, 103 (03) : 491 - 495
  • [28] Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
    Ertugrul, Derun Taner
    Kan, Erdal
    Tura, Cigdem Bahadir
    Tugtekin, Haci Bayram
    Ayakta, Hayati
    Celebioglu, Mehmet
    Yilmaz, Ceren
    Utebay, Onur
    Yetkin, Ilhan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (01) : 147 - 160
  • [29] Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes
    Inzucchi, Silvio E.
    Davies, Melanie J.
    Khunti, Kamlesh
    Trivedi, Prabhav
    George, Jyothis T.
    Zwiener, Isabella
    Johansen, Odd Erik
    Sattar, Naveed
    DIABETES OBESITY & METABOLISM, 2021, 23 (02) : 425 - 433
  • [30] Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
    Scheerer, Markus F.
    Rist, Roland
    Proske, Orm
    Meng, Annika
    Kostev, Karel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 337 - 345